FDADecember 29, 2021drug

Pioglitazone Tablets USP, 45 mg, 500 count bottles, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ -- NDC 57237-221-05

Official recall recorded by the U.S. Food & Drug Administration.

The hazard

Superpotent and Failed Tablet/Capsule Specifications

What to do

FDA enforcement status: Terminated

Brands named

aurobindo pharmaaurobindo

Recall history

Other federal recalls tied to the same brand — a factual pattern, straight from the source data.

Own something like this?

AllClear screens your whole list against every CPSC, FDA, USDA and NHTSA recall — and tells you the day a new one names something you own.

Start free — 200 items, no card →